Reverse Therapy UK Limited Company Profile

06:00 EDT 22nd March 2018 | BioPortfolio

John Eaton is the Founder of Reverse Therapy and has been innovating in the field of therapy since 1988. Since 1996 he has been steadily developing the ideas, techniques and principles that, collectively, he named 'Reverse Therapy' in 2002.
He has brought together a unique blend of insights drawn from Bodymind healing techniques, Symptom-focused therapy and Psychobiology that forms a powerful application to many different types of symptomatic states, including M.E., Chronic Fatigue Syndrome and Fibromyalgia.
John is also the lead Trainer on all Reverse Therapy training courses and is well known for his wit and humour, and the precision of his training methods.
John graduated with a doctorate from Lancaster University Department of Psychology in 1998 and is a member of the British Psychological Society. Since 1991 he has trained or supervised over 700 individuals in a variety of therapy approaches and has delivered over 18000 therapy hours to clients.


The Old Bakery4 Church Street
RG17 9TR
United Kingdom


Phone: 01488 608505

News Articles [1213 Associated News Articles listed on BioPortfolio]

Novel Agent may Reverse Resistance to Targeted Therapy in Acute Leukemia and MDS

After discovering how some hematologic cancer cells manage to elude death from a targeted therapy, Dana-Farber Cancer Institute scientists have […] The post Novel Agent may Reverse Resistance to...

BiomX Wants To Reverse The Focus Of Microbiome Therapy

Emerging Company Profile: Where other microbiome-focused firms seek to add bacteria to the patient's gut, Israel's BiomX thinks it can...   

Mobile health, ketogenic diet reverse type 2 diabetes after one year

Researchers from Purdue University, IU Health Arnett and Virta Health have found the com

Exercise routine ‘should be prescription for life to reverse heart risk’ – HeraldScotland

HeraldScotlandExercise routine 'should be prescription for life to reverse heart risk'HeraldScotlandWalking, swimming and running could help middle-aged couch potatoes reverse their risk of heart fail...

Why Spark and Watchdog ICER Don’t See Eye-to-Eye on $850K Gene Therapy

The first gene therapy approved in the U.S. costs $850,000. Announcing the price on Jan. 3, its owner Spark Therapeutics held out the possibility of some relief, such as installment payments, or slim ...

[Comment] Combination ART: are two drugs as good as three?

The first 10 years of the development of antiretroviral therapy (ART) were characterised by a series of studies that led to the conclusion that triple therapy was the minimum required to induce and ma...

Managing antibiotics not enough to reverse resistance

(Duke University) Researchers at Duke University have discovered that reducing the use of antibiotics will not be enough to reverse the growing prevalence of antibiotic resistance because bacteria are...

The Blockbuster That Wasn't -- A CETP Inhibitor Post-Mortem

The quest for the “holy grail” of cardiovascular therapy - a drug that dramatically lowered LDL-c and raised HDL-c and which would hopefully reverse atherosclerosis - has ended ignominiously.

PubMed Articles [2605 Associated PubMed Articles listed on BioPortfolio]

Time course of secondary mitral regurgitation in patients with heart failure receiving cardiac resynchronization therapy: Impact on long-term outcome beyond left ventricular reverse remodelling.

The prognostic value of secondary mitral regurgitation (MR) at baseline versus immediately after and several months after cardiac resynchronization therapy (CRT), beyond left ventricular (LV) reverse ...

Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.

An ischemic etiology of heart failure(HF) has been associated with reduced left ventricular reverse remodeling following cardiac resynchronization therapy(CRT).

Maximizing Home Equity or Preventing Home Loss: Reverse Mortgage Decision Making and Racial Inequality.

Reverse mortgages are loans that allow older homeowners to borrow from their home equity with no repayment due until the borrower dies or moves out of the home. We currently know very little about how...

Screening Veterans for Syphilis: Implementation of the Reverse Sequence Algorithm.

We evaluated the syphilis reverse sequence algorithm (RSA) in a Veteran Affairs facility, finding 5.5% reactive Treponema pallidum enzyme immunoassay (EIA) tests. In a subset of EIA+/VDRL-/TP-PA+ case...

Nucleoside/nucleotide reverse transcriptase inhibitors attenuate angiogenesis and lymphangiogenesis by impairing receptor tyrosine kinases signalling in endothelial cells.

Cardiovascular disease associated with antiretroviral therapy (ART) has become a major clinical challenge for HIV-positive patients. However, the role of ART in blood vessel growth is largely unknown....

Clinical Trials [2090 Associated Clinical Trials listed on BioPortfolio]

Comparing the Efficacy of 14-day Reverse Hybrid Therapy and 14-day Triple Therapy Plus Bismuth Therapy

Reverse hybrid therapy achieves a higher eradication rate than bismuth (triple therapy plus bismuth) remains unanswered

Comparing the Efficacy of Reverse Hybrid Therapy and Concomitant Therapy

Reverse hybrid therapy achieves a higher eradication rate than concomitant therapy remains unanswered.

Axillary Reverse Mapping for Invasive Carcinoma of the Breast

Primary Objectives: - To determine the feasibility of axillary reverse mapping (ARM) in patients undergoing axillary lymph node dissection for breast cancer therapy. - T...

Reverse Shoulder Prosthesis Study

The objective of this clinical study is to evaluate the safety and efficacy of the Encore Reverse Shoulder Prosthesis (RSP). The clinical results of the RSP will be compared to clinical re...

Retrospective Encore Reverse Shoulder Prosthesis Study

The purpose of this study is to evaluate the survivorship and efficacy of the Encore Reverse Shoulder Prosthesis in a group of no more than 50 subjects for whom data collection has already...

Companies [964 Associated Companies listed on BioPortfolio]

Reverse Therapy UK Limited

John Eaton is the Founder of Reverse Therapy and has been innovating in the field of therapy since 1988. Since 1996 he has been steadily developing the ideas, techniques and principles that, collectiv...


Bioxyne Limited (ASX:BXN) is an Australian immunotherapeutics business created in April 2012 through the reverse takeover of Probiomics (ASX: PCC) by privately held Hunter Immunology. The Company&rs...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Therapy Source, Inc.

Therapy Source, a premier therapy staffing provider, offers highly qualified speech, occupational, physical, psychological and related therapy services to educational and healthca...

Apria Healthcare Group Inc.

Apria is a privately held company owned by a group of investment limited partnerships managed by affiliates of Blackstone (NYSE:BX). Through its Apria Healthcare LLC operating uni...

More Information about "Reverse Therapy UK Limited" on BioPortfolio

We have published hundreds of Reverse Therapy UK Limited news stories on BioPortfolio along with dozens of Reverse Therapy UK Limited Clinical Trials and PubMed Articles about Reverse Therapy UK Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Reverse Therapy UK Limited Companies in our database. You can also find out about relevant Reverse Therapy UK Limited Drugs and Medications on this site too.

Quick Search


Relevant Topics

Sleep Disorders
Sleep disorders disrupt sleep during the night, or cause sleepiness during the day, caused by physiological or psychological factors. The common ones include snoring and sleep apnea, insomnia, parasomnias, sleep paralysis, restless legs syndrome, circa...

Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Corporate Database Quicklinks

Searches Linking to this Company Record